Thema: US4781601046
Johnson & Johnson, US4781601046
Flatlay-Arrangement mit Aktienzertifikat und ISIN-Karte symbolisiert Aktie von Johnson & Johnson, ISIN US4781601046, im Pharmasektor - Foto: THN
Johnson & Johnson stock: 26 Impella presentations set for TCT 2026
Johnson & Johnson stock heads into TCT with fresh Impella evidence. The program spans heart recovery, high-risk procedures and next-generation devices.
ad-hoc-news.de, heute 11:14 Uhr
Johnson & Johnson, US4781601046
Johnson & Johnson stock: New Impella evidence ahead of TCT ...
Johnson & Johnson stock gets a new MedTech data point ahead of the TCT conference. The company will present Impella research in San Diego.
ad-hoc-news.de, 29.10.26 17:51 Uhr
Johnson & Johnson, US4781601046
Johnson & Johnson stock schedules December 8 review: rises ...
Johnson & Johnson stock is 0.31 percent above the Xetra close of October 27 2026 in pre-market trading. The company has scheduled an Enterprise Business Review for December ...
ad-hoc-news.de, 28.10.26 07:39 Uhr
Johnson & Johnson, US4781601046
Morgan Stanley cuts target for Johnson & Johnson stock from ...
The USD 1.34 dividend pays on December 8, 2026. Johnson & Johnson stock costs EUR 239.95 on October 27, 2026, unchanged versus Xetra close.
ad-hoc-news.de, 27.10.26 18:16 Uhr
Johnson & Johnson, US4781601046
Scotiabank sets a USD 305.00 target for Johnson & Johnson ...
Q3 sales rose 5.90 percent to USD 25.40 billion. Johnson & Johnson stock costs EUR 239.15 on October 27, 2026, 1.65 percent below its high.
ad-hoc-news.de, 27.10.26 11:27 Uhr
Johnson & Johnson, US4781601046
Johnson & Johnson stock pre-market at EUR 238.85: healthcare ...
Johnson & Johnson stock is 0.70 percent above the Xetra close of October 26 2026 in pre-market trading. At Lang & Schwarz the stock trades at EUR 238.85 on October 27 2026. ...
ad-hoc-news.de, 27.10.26 08:15 Uhr
Johnson & Johnson, US4781601046
Johnson & Johnson sales rose 5.90 percent. Johnson & Johnson ...
Earnings beat by USD 0.05 in the third quarter. Johnson & Johnson stock costs EUR 238.00 on October 26, 2026, up 1.26 percent versus Xetra close.
ad-hoc-news.de, 26.10.26 16:40 Uhr
Johnson & Johnson, US4781601046
Johnson & Johnson raised 2026 guidance. Johnson & Johnson ...
Johnson & Johnson raised its 2026 outlook on October 13, 2026. Johnson & Johnson stock costs EUR 237.50, 1.04 percent above Xetra.
ad-hoc-news.de, 26.10.26 11:36 Uhr
Johnson & Johnson, US4781601046
Johnson & Johnson stock: Healthcare group trades pre-market ...
Johnson & Johnson develops treatments and solutions for patients and professionals. At Lang & Schwarz the stock trades pre-market at EUR 235.78 on October 26 2026 0.31 percent ...
ad-hoc-news.de, 26.10.26 08:19 Uhr
Johnson & Johnson, US4781601046
Johnson & Johnson reports data. Johnson & Johnson stock ...
